These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 423182)

  • 41. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New N-amino acid derivatives of daunorubicin.
    Dzieduszycka M; Stefanska B; Borowski E; Martelli S
    Farmaco Sci; 1986 Nov; 41(11):881-91. PubMed ID: 3803566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
    Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 4-Demethoxy-4-alkoxydaunorubicins.
    Bernardi L; Masi P; Sapini O; Suarato A; Arcamone F
    Farmaco Sci; 1979 Oct; 34(10):884-9. PubMed ID: 510530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adriamycin analogues. Preparation and biological evaluation of some novel 14-thiaadriamycins.
    Seshadri R; Israel M; Pegg WJ
    J Med Chem; 1983 Jan; 26(1):11-5. PubMed ID: 6827523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and antitumor activity of 4'-O-methyldaunorubicin, 4'-O-methyladriamycin, and their 4'-epi analogues.
    Cassinelli G; Ruggieri D; Arcamone F
    J Med Chem; 1979 Feb; 22(2):121-3. PubMed ID: 423191
    [No Abstract]   [Full Text] [Related]  

  • 48. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK; Chitnis MP; Embrey WM; Gregory EB
    Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2-Deaminoactinomycin D, synthesis and interaction with deoxyribonucleic acid.
    Mosher CW; Kuhlmann KF; Kleid DG; Henry DW
    J Med Chem; 1977 Aug; 20(8):1055-9. PubMed ID: 330857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total chemical synthesis and antitumor evaluation of the 9-aza analogue of N-(trifluoroacetyl)-4-demethoxydaunomycin.
    Mitscher LA; Gill H; Filppi JA; Wolgemuth RL
    J Med Chem; 1986 Jul; 29(7):1277-81. PubMed ID: 3806577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
    McGovren JP
    Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD; Bachur NR
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract]   [Full Text] [Related]  

  • 53. 3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
    Horton D; Priebe W; Varela O
    J Antibiot (Tokyo); 1984 Dec; 37(12):1635-41. PubMed ID: 6549317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone.
    Arcamone F; Penco S; Vigevani A; Redaelli S; Franchi G; DiMarco A; Casazza AM; Dasdia T; Formelli F; Necco A; Soranzo C
    J Med Chem; 1975 Jul; 18(7):703-7. PubMed ID: 168385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential antitumor agents. Some sulfur-substituted derivatives of alpha- and beta-2'-deoxythioguanosine.
    Martinez AP; Lee WW; Henry DW
    J Med Chem; 1977 Mar; 20(3):341-4. PubMed ID: 845866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
    Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
    J Med Chem; 1990 Sep; 33(9):2375-9. PubMed ID: 2391681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
    Arcamone F; Bernardi L; Giardino P; Patelli B; Marco A; Casazza AM; Pratesi G; Reggiani P
    Cancer Treat Rep; 1976 Jul; 60(7):829-34. PubMed ID: 1009518
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Syntheses and biological activities of 3'-azido disaccharide analogues of daunorubicin against drug-resistant leukemia.
    Zhang G; Fang L; Zhu L; Zhong Y; Wang PG; Sun D
    J Med Chem; 2006 Mar; 49(5):1792-9. PubMed ID: 16509594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 4-Demethoxy-4-hydroxydaunorubicin 6-methyl ether and 11-methyl ether, two active isomers of daunorubicin.
    Masi P; Suarato A; Giardino P; Iraci G; Bernardi L; Arcamone F
    Farmaco Sci; 1980 May; 35(5):347-56. PubMed ID: 7450036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.